A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort by 이삭 et al.
88 http://www.jchestsurg.org
JCS
Journal of Chest Surgery
Clinical
Research
A Risk Prediction Model for Operative Mortality after Heart 
Valve Surgery in a Korean Cohort
Ho Jin Kim, M.D.1, Joon Bum Kim, M.D., Ph.D.1, Seon-Ok Kim, M.Sc.2, Sung-Cheol Yun, Ph.D.2, Sak Lee, M.D., Ph.D.3, 
Cheong Lim, M.D., Ph.D.4, Jae Woong Choi, M.D.5, Ho Young Hwang, M.D., Ph.D.5, Kyung Hwan Kim, M.D.5,  
Seung Hyun Lee, M.D., Ph.D.3, Jae Suk Yoo, M.D., Ph.D.6, Kiick Sung, M.D., Ph.D.7, Hyung Gon Je, M.D., Ph.D.8,  
Soon Chang Hong, M.D., Ph.D.9, Yun Jung Kim, R.N., Ph.D.10, Sung-Hyun Kim, M.S.10, Byung-Chul Chang, M.D, Ph.D., 
F.A.H.A.11
Departments of 1Thoracic and Cardiovascular Surgery and 2Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of 
Medicine; 3Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul; 4Department of Thoracic and 
Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam; 5Department of Thoracic and 
Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; 6Department of Cardiovascular Surgery, Sejong 
General Hospital, Bucheon; 7Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 
Seoul; 8Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Yangsan; 9Department of Thoracic and Cardiovascular 
Surgery, Wonju Severance Christian Hospital, Wonju; 10National Evidence-based Healthcare Collaborating Agency, Seoul; 11Department of Thoracic and 
Cardiovascular Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
ARTICLE INFO
Received  July 28, 2020
Revised  September 7, 2020
Accepted  September 9, 2020 







Background: This study aimed to develop a new risk prediction model for operative 
mortality in a Korean cohort undergoing heart valve surgery using the Korea Heart Valve 
Surgery Registry (KHVSR) database.
Methods: We analyzed data from 4,742 patients registered in the KHVSR who under-
went heart valve surgery at 9 institutions between 2017 and 2018. A risk prediction model 
was developed for operative mortality, defined as death within 30 days after surgery or 
during the same hospitalization. A statistical model was generated with a scoring system 
by multiple logistic regression analyses. The performance of the model was evaluated by 
its discrimination and calibration abilities.
Results: Operative mortality occurred in 142 patients. The final regression models identi-
fied 13 risk variables. The risk prediction model showed good discrimination, with a c-sta-
tistic of 0.805 and calibration with Hosmer-Lemeshow goodness-of-fit p-value of 0.630. 
The risk scores ranged from -1 to 15, and were associated with an increase in predicted 
mortality. The predicted mortality across the risk scores ranged from 0.3% to 80.6%.
Conclusion: This risk prediction model using a scoring system specific to heart valve 
surgery was developed from the KHVSR database. The risk prediction model showed that 
operative mortality could be predicted well in a Korean cohort.
Keywords: Risk prediction model, Mortality, Heart valve surgery
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Introduction
Cardiovascular disease is the second most common 
cause of death in Korea [1], and valvular heart disease has 
been reported to affect approximately 9% of the Korean 
population [2]. Despite the recent rapid adoption of alter-
nate transcatheter valve therapy [3,4], the number of heart 
valve operations has gradually increased owing to the 
growth of the aging population [5]. Approximately 14,000 
cardiac surgical procedures are performed annually, and 
heart valve surgery has outpaced coronary artery bypass 
grafting (CABG) to become the most common cardiac 
procedure performed in Korea [6].
Risk assessment is an essential part of preoperative plan-
ning, both for cardiac surgeons and for patients and their 
families, and may contribute to the improved safety and 
quality of cardiac surgery. As such, 2 risk prediction mod-
els have been developed in the United States and Europe 
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based on the nationwide or international cardiac surgery 
databases [7,8]. Although these risk prediction models have 
been widely adopted among global cardiac surgery com-
munities, it has been suggested that a nation-specific risk 
prediction model that is developed based on a unique na-
tional database may predict the risk of surgery more ade-
quately than the US or European models [9,10].
The Korea Heart Valve Surgery Registry (KHVSR) was 
established as an official heart valve surgery database ini-
tiative of the Korean Society of Thoracic and Cardiovascu-
lar Surgery in 2017. Using this database, we developed the 
first risk prediction model for operative mortality in pa-
tients who undergo heart valve surgery in Korea.
Methods
Study cohort
The clinical and operative data of patients who under-
went heart valve surgery at the 13 participating institutions 
in Korea have been prospectively registered in the KHVSR 
since January 2017. From the KHVSR database, we identi-
fied patients who received valve replacement/repair surgery 
with or without concomitant procedures between January 
1, 2017 and December 31, 2018 from 9 of the 13 institutions 
that agreed to provide institutional data to develop the risk 
prediction model. This study was approved by the Institu-
tional Review Board and Ethics Committee of each partic-
ipating institution and the National Evidence-based 
Healthcare Collaborating Agency (IRB approval no., 19-
018-01). Informed consent was obtained from the patients 
who agreed to provide their clinical data to be registered in 
the KHVSR database.
Data collection
The KHVSR database contains information on each pa-
tient’s preoperative risk profiles, laboratory and echocar-
diographic data, intraoperative details, and postoperative 
mortality and complications. Data were prospectively col-
lected by a data manager or an operating surgeon at each 
participating institution using a dedicated electronic case 
report form (available online at http://heartvalve.or.kr). All 
patients who underwent heart valve surgery between Janu-
ary 1, 2017 and December 31, 2018 at the 9 institutions 
were registered in the KHVSR.
After the collection of data, all data were verified and 
queried for missing values or outliers by the first author 
(H.J.K.). The authors at each participating institution were 
responsible for the completion of data collection: data were 
validated by the authors at each institution, and an exter-
nal audit was also performed on-site to evaluate the consis-
tency and accuracy of the data.
Statistical analyses
SAS software ver. 9.4 (SAS Institute Inc., Cary, NC, USA) 
and R software ver. 3.6.1 (R Foundation for Statistical 
Computing, Vienna, Austria; http://www.r-project.org/) 
were used for the statistical analyses. Categorical variables 
were presented as means±standard deviations, and contin-
uous variables were presented as frequencies or propor-
tions with percentages. Missing values were handled using 
the Markov chain Monte Carlo single-imputation method.
The primary endpoint for the risk prediction model was 
operative mortality that occurred within 30 days of surgery 
or during the same hospitalization period. To estimate the 
significant risk factors for operative mortality, multivari-
able logistic regression analyses were performed. Of all 
data fields registered in the KHVSR, the authors a priori 
reviewed and selected 25 potentially relevant risk variables 
listed in Table 1. The number of operated valves (Table 2) 
and concomitant procedures (Table 3) were also primarily 
fitted in the univariable models.
The multivariable models were validated with a boot-
strap method that generated 1,000 random samples 
(n=4,742) with replacement. A stepwise backward elimina-
tion process was performed in every bootstrap sample to 
evaluate the reliability of risk variables to be retained in 
the final risk prediction models, and risk variables selected 
≥400 times in the 1,000 bootstrap models were then re-
tained in the final risk prediction model [11]. Although the 
extent of the procedure, which was quantified as the num-
ber of operated valves (Table 2), was not retained in the fi-
nal model, we assumed that the extent of the procedure 
may have significant clinical implications. Accordingly, we 
developed 2 risk prediction models depending on the fit-
ting of the extent of the procedure. All reported p-values 
were 2-tailed, and p-values <0.05 were considered to indi-
cate statistical significance.
The risk prediction models were developed using a scor-
ing system based on penalized maximum likelihood esti-
mates of each risk variable. The multivariable logistic re-
gression β coefficient of each risk variable was transformed 
into an integer risk score by rounding the quotient of the β 
coefficient divided by a single constant. The constant was 
the β coefficient for a 20-year increment in age, thereby al-





Table 1. Baseline characteristics of the study population
Characteristic Value No. of missing data
Age (yr) 62.4±13.2 2
   ≥80 282 (5.9)
   ≥60 and <80 2,727 (57.5)
   <60 1,731 (36.5)
Female 2,242 (47.3) 0
Body mass index (kg/m2) 23.9±3.6 2
Smoking history 8
   Never smoker 3,448 (72.7)
   Current smoker 392 (8.3)
   Previous smoker 894 (18.9)
Emergency or urgency 366 (7.7) 0
New York Heart Association class 3 or 4 1,235 (26.0) 0
Preoperative heart rhythm 0
   Normal sinus rhythm 3,011 (63.5)
   Atrial fibrillation 1,594 (33.6)
   Others 137 (2.9)
Hypertension 2,165 (45.7) 0
Diabetes 896 (18.9) 0
Dyslipidemia 1,244 (26.2) 0
Chronic kidney disease 364 (7.7) 0
Dialysis 132 (2.8) 0
Chronic lung disease 315 (6.6) 0
Peripheral arterial occlusive disease 264 (5.6) 0
History of stroke 364 (7.7) 0
Infective endocarditis 347 (7.3) 0
Previous cardiac surgery 812 (17.1) 0
History of myocardial infarction 140 (3.0) 3
Hemoglobin (g/dL) 12.5±2.0 2
   ≥13 2,071 (43.7)
   <13 2,669 (56.3)
Estimated glomerular filtration rate (mL/min/1.73 m2) 75.7±25.9 3
   ≥60 3,638 (76.8)
   ≥30 and <60 871 (18.4)
   <30 230 (4.6)
Echocardiographic profile
   LV ejection fraction (%) 58.8±10.8 34
      ≥55 3,512 (74.6)
      ≥30 and <55 1,104 (23.5)
      <30 92 (2.0)
   LV end­systolic dimension (mm) 35.6±9.1 56
   LV end­diastolic dimension (mm) 53.9±9.4 46
   Systolic pulmonary artery pressure (mm Hg) 37.8±16.1 402
   Aortic valve diseasea) 17
      Severe aortic stenosis 1,728 (36.6)
      Significant aortic regurgitation (≥moderate) 606 (12.8)
   Mitral valve diseasea) 17
      Severe mitral stenosis 590 (12.5)
      Significant mitral regurgitation (≥moderate) 1,288 (27.3)
   Tricuspid regurgitation 38
      None­to­trivial 2,636 (56.0)
      Mild 1,097 (23.3)
      Moderate 409 (8.7)
      Severe 562 (11.9)
Values are presented as mean±standard deviation or number (%), unless otherwise stated.
LV, left ventricular.
a)Included only the patients with native valve disease and excluded the patients with valve disease from infectious etiology.
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point. Therefore, the total risk score for each patient was 
calculated as the sum of the risk score for the selected vari-
ables.
The discrimination and calibration abilities of the risk 
prediction models were assessed with the c-statistic and 
Hosmer-Lemeshow goodness-of-fit test. For internal vali-
dation, 1,000 random bootstrap samples with replacement 
(n=4,742) were drawn to obtain an optimism-corrected 
c-statistic [12]. Additionally, the performance of the risk 
prediction models was also validated on external cohorts 
composed of patients who underwent surgery between Jan-
uary 2019 and June 2019 and were then registered in the 
KHVSR until November 30, 2019. In the development and 
validation set, calibration was also assessed by plotting ac-
tual versus predicted mortality rates across deciles of pre-
dicted risk [13].
Results
Baseline characteristics and operative profiles
A total of 4,766 patients who underwent heart valve sur-
gery at the 9 participating institutions were registered in 
the KHVSR during the study period. Of them, 24 patients 
who underwent cardiac surgery other than valve replace-
ment/repair surgery were excluded. Consequently, 4,742 
patients were enrolled in this study.
Table 1 summarizes the baseline characteristics of the 
study cohort. The mean age of the patients was 62.4±13.2 
years, and 2,242 (47.3%) were women. Non-elective surgery 
accounted for 7.7% of the patients (n=366), and 812 pa-
tients (17.1%) had a history of previous cardiac surgery. 
Isolated valve surgery was performed in 3,471 patients 
(73.2%), whereas the remaining 1,271 (26.8%) underwent 
combined valve surgery (Table 2, Supplementary Fig. 1). 
Concomitant procedures were performed in 1,789 patients 
(37.7%), and 160 (3.4%) received ≥2 types of concomitant 
procedures (Table 3). Atrial fibrillation (AF) surgery was 
most frequently performed concomitantly in these patients 
(n=976, 20.6%), followed by aorta replacement (n=493, 
10.4%) and CABG (n=346, 7.3%).
Table 2. Operative profiles and sample sizes
Operation No. of cases
Isolated valve surgery 3,471
   Aortic valve replacement 1,845
   Mitral valve replacement 462
   Mitral valve repair 611
   Tricuspid valve replacement 82
   Tricuspid valve repair 187
   Pulmonary valve surgery 14
   Aortic root reimplantation (David) 52
   Aortic root replacement (Bentall) 218
Combined valve surgery (double valve) 1,075
   Aortic valve replacement+mitral valve 
replacement
218
   Aortic valve replacement+mitral valve repair 50
   Aortic valve replacement+tricuspid valve 
repair
94
   Aortic valve replacement+tricuspid valve 
replacement
15
   Aortic valve replacement+pulmonary valve 
surgery
1
   Mitral valve replacement+aortic root surgerya) 3
   Mitral valve replacement+tricuspid valve 
repair
434
   Mitral valve replacement+tricuspid valve 
replacement
21
   Bentall operation+mitral valve repair 6
   Bentall operation+tricuspid valve repair 5
   Bentall operation+tricuspid valve 
replacement
1
   Bentall operation+pulmonary valve surgery 2
   David operation+mitral valve repair 6
   David operation+tricuspid valve repair 1
   Mitral valve repair+tricuspid valve repair 209
   Mitral valve repair+tricuspid valve 
replacement   
4
   Tricuspid valve repair+pulmonary valve 
surgery
4
   Tricuspid valve replacement+pulmonary 
valve surgery
1
Combined valve surgery (triple valve) 196
   Aortic valve+mitral valve+tricuspid valve 
surgery
188
   Aortic valve+mitral valve+pulmonary valve 
surgery
1
   Bentall+mitral valve+tricuspid valve surgery 4
   Bentall+tricuspid valve+pulmonary valve 
surgery
3
a)Included both aortic root reimplantation (David operation) and aortic 
root replacement (Bentall operation).
Table 3. Concomitant procedures
Concomitant procedures No. of cases (%)
Coronary artery bypass grafting 346 (7.3)
Atrial fibrillation surgery 976 (20.6)
Aorta replacement 493 (10.4)
Cardiac tumor resection 6 (0.1)








Operative mortality occurred in 142 patients (3.0%). Of 
these, 87 and 55 patients underwent isolated and combined 
valve surgery, respectively (Supplementary Table 1). The 
operative mortality rate according to the number of oper-
ated valves was 2.5% for an isolated valve, 4.1% for a double 
valve, and 5.6% for a triple valve. Among patients who un-
derwent concomitant CABG (n=346) and AF surgery 
(n=976), operative mortality occurred in 24 patients (6.9%) 
and 26 patients (2.7%), respectively (Supplementary Table 
2).
Development of risk prediction models for 
operative mortality
Twenty risk variables were identified as candidate vari-
ables in the univariable logistic regression analyses (Sup-
plementary Table 3). In the 1,000 bootstrap random sam-
ples, 13 risk variables emerged as significant predictors for 
operative mortality with a frequency of ≥400 in the multi-
variable analyses (model 1 in Table 4): age, New York Heart 
Association class 3 or 4, elective versus non-elective sur-
gery, body mass index (BMI), diabetes, infective endocar-
ditis, estimated glomerular filtration rate (eGFR), history 
of stroke, previous cardiac surgery, anemia (hemoglobin 
<13 g/dL) [14], concomitant CABG, left ventricular (LV) 
dysfunction (LV ejection fraction), and significant tricus-
pid regurgitation. In model 2, the number of operated 
valves was also incorporated as a risk variable (Table 4). 
Regarding statistical performance, models 1 and 2 achieved 
adequate discrimination, with c-statistics of 0.805 and 
0.804, respectively; calibration ability was also acceptable, 
with Hosmer-Lemeshow p-values of 0.630 and 0.494, re-
spectively.
Continuous variables were categorized into risk groups 
based on clinical implications or with reference to previous 
studies [7,14-16]. The β coefficient for a 20-year increment 
in age was 0.446 in model 1 and 0.440 in model 2. The β 
coefficients of risk variables in each risk prediction model 
were converted to risk scores (Table 5). Of note, BMI values 
≥25 kg/m2 were found to have a negative predictive value 
for operative mortality in model 1 (β coefficient=-0.375) 
and model 2 (β coefficient=-0.360). Thus, the sum of the 
risk scores ranged from -1 to 15 in model 1, and from -1 to 
16 in model 2. The risk scores of the study cohort ranged 
from -1 to 11 in model 1, and from -1 to 12 in model 2 (Fig. 
1). The incidence of postoperative mortality tended to be 
higher in patients with higher risk scores in both model 1 
(Fig. 1A) and model 2 (Fig. 1B). The mortality rate was 
Table 4. Risk variables for operative mortality in the multivariable logistic regression models
Risk factors
Multivariable model 1 Multivariable model 2
OR (95% CI) p­value OR (95% CI) p­value
Age 1.02 (1.01–1.04) 0.005 1.02 (1.01–1.04) 0.005
New York Heart Association class 3 or 4 1.41 (1.00–1.99) 0.0501 1.40 (0.995–1.96) 0.053
Elective vs. emergency/urgency 2.07 (1.37–3.14) <0.001 2.05 (1.36–3.08) 0.001
Body mass index 0.93 (0.88–0.98) 0.004 0.93 (0.88–0.98) 0.005
Diabetes 1.39 (0.96–2.01) 0.081 1.39 (0.96–1.99) 0.078
Infective endocarditis 1.58 (0.98–2.53) 0.056 1.54 (0.98–2.43) 0.064
Estimated glomerular filtration rate (mL/min/1.73 m2)
   ≥60 vs. 30–60 1.52 (1.03–2.25) 0.034 1.51 (1.03–2.21) 0.034
   ≥60 vs. <30 2.67 (1.68–4.23) <0.001 2.59 (1.65–4.06) <0.001
History of stroke 1.60 (1.02–2.50) 0.041 1.55 (0.998–2.40) 0.051
Previous cardiac surgery 1.86 (1.29–2.68) 0.001 1.82 (1.27–2.61) 0.001
Concomitant coronary artery bypass grafting 1.94 (1.26–3.07) 0.005 1.90 (1.21–2.98) 0.005
Hemoglobin (mg/dL) 0.86 (0.78–0.94) 0.001 0.85 (0.78–0.94) 0.001
Echocardiographic profile
   Left ventricular ejection fraction (%) 0.99 (0.97–0.99) 0.043 0.99 (0.97–1.00) 0.044
   Tricuspid regurgitation
      ≤Mild vs. ≥moderate 1.51 (1.05–2.16) 0.025 1.39 (0.95–2.04) 0.095
No. of operated valves
   Isolated vs. combined (double) 1.15 (0.78–1.69) 0.490
   Isolated vs. combined (triple) 1.29 (0.73–2.27) 0.383
OR, odds ratio; CI, confidence interval.
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lower in patients with scores of -1 to 4 (1.2%) than the av-
erage rate (3.0%) (Supplementary Table 4). In the subgroup 
of patients with a risk score ≥5, the mortality rate was 
found to be significantly increased in patients with a score 
≥7.
Table 6 demonstrates the predicted probability rates for 
operative mortality as a function of the risk score. Based 
on the estimated total risk scores, the predicted risk of 
mortality ranged from 0.3% to 80.6% in model 1, and from 
0.3% to 85.5% in model 2.
Validation of risk prediction models
Internal bootstrapping validation on 1,000 samples 
demonstrated an optimism-corrected c-statistic of 0.792 
(95% confidence interval [CI], 0.755–0.829) in model 1, and 
0.789 (95% CI, 0.753–0.826) in model 2, thereby indicating 
that the performance of the risk prediction model was 
good. These risk prediction models were also externally 
validated on 639 patients registered in the KHVSR who 
underwent surgery from January 2019 to June 2019. The 
c-statistic was 0.845 (95% CI, 0.719–0.972) for model 1 and 
0.842 (95% CI, 0.715–0.969) for model 2. The calibration 
abilities assessed by the Hosmer-Lemeshow goodness-of-fit 
test were also acceptable in model 1 (p=0.637) and model 2 
(p=0.675). Calibration graphs also demonstrated accept-
able calibrations for operative mortality in the development 
(Fig. 2) and validation sets (Fig. 3).
Discussion
The major findings of this study relate to the develop-
ment of risk prediction models for operative mortality fol-
lowing heart valve surgery, using a cohort that constituted 
Table 5. β coefficients and risk scores for operative mortality
Risk factors
Model 1 Model 2
β coefficient Risk score β coefficient Risk score
Age (yr)
   ≥60 and <70 0.368 1 0.363 1
   ≥70 and <80 0.579 1 0.572 1
   ≥80 0.757 2 0.747 2
New York Heart Association class
   Class 1 or 2 vs. 3 or 4 0.344 1 0.334 1
Elective vs. emergency/urgency 0.727 2 0.717 2
Body mass index (kg/m2)
   <20 0.319 1 0.306 1
   ≥25 ­0.375 ­1 ­0.360 ­1
Diabetes 0.329 1 0.326 1
Infective endocarditis 0.458 1 0.432 1
Estimated glomerular filtration rate (mL/min/1.73 m2)
   <30 0.981 2 0.951 2
   ≥30 and <60 0.422 1 0.413 1
History of stroke 0.468 1 0.437 1
Hemoglobin (mg/dL)
   <13 vs. ≥13 0.500 1 0.510 1
Left ventricular ejection fraction (%)
   <30 0.574 1 0.569 1
   ≥30 and <55 0.258 1 0.255 1
Tricuspid regurgitation
   ≤Mild vs. ≥moderate 0.410 1 0.327 1
Previous cardiac surgery 0.618 1 0.598 1
Concomitant coronary artery bypass grafting 0.663 1 0.640 1
No. of operated valves
   Isolated vs. double valve NA NA 0.137 0
   Isolated vs. triple valve NA NA 0.252 1






a majority of the recent clinical outcomes of patients in 
Korea. The KHVSR was established in 2017 by the Korean 
Society of Thoracic and Cardiovascular Surgery as a na-
tionwide collaborative effort to improve the quality of 
heart valve surgery and to enhance research activities. By 
generating a risk prediction model from the KHVSR data-
base, this study presents an up-to-date multi-institutional 
analysis of operative mortality after heart valve surgery 
across medium- to high-volume hospitals in Korea. The 
risk prediction model was generated based on a readily cal-
culable scoring system and was shown to perform well in a 
contemporary heart valve surgery cohort in Korea. This 
study, to our knowledge, represents the largest and most 
current analysis of nationwide operative outcomes, partic-
ularly dedicated to the wide spectrum of heart valve sur-
gery with or without concomitant procedures. Therefore, 
we speculated that these risk prediction models may sup-
port cardiac surgeons and healthcare providers in obtain-
ing more accurate assessments of operative mortality, as 
well as in counseling patients and families who are consid-
ering heart valve surgery in Korea.
The US- and Europe-derived risk prediction models have 
been most commonly used to assess the risk of cardiac sur-
gery in Korea [7,8]. However, the performance of these risk 
prediction models has been frequently challenged for a 
specific regional population, subgroups of a particular dis-
ease [17], or specific types of cardiac procedure [18,19]. The 
European System for Cardiac Operative Risk Evaluation 
(EuroSCORE) II model was generated to assess the mortal-
ity risk of all types of cardiac procedures [7]. However, it 
has been suggested that the EuroSCORE II risk prediction 
model may not perform well for patients undergoing heart 
valve surgery with or without combined procedures [20], 
or those in endemic areas of rheumatic heart disease [21]. 
The Society of Thoracic Surgeons (STS) risk prediction 
models are procedure-specific and only evaluate sin-
gle-valve surgery, such as aortic/mitral valve replacement 













































































































Fig. 1. Risk scores and the rate of 
operative mortality in model 1 (A) 
and model 2 (B) after heart valve 
surgery.
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to the 26.8% of patients who underwent multi-valve sur-
gery (n=1,271) in our cohort.
Compared to other developed countries, Korea has 
unique demographic features: specifically, the aging popu-
lation is growing faster than that in any other region in the 
world [5,22], and there is still a high prevalence of rheu-
matic heart disease, which is known to be generally preva-
lent in developing countries [23]. Moreover, coronary by-
pass surgery is less frequently performed than in other 
countries, as demonstrated by the reported ratio of percu-
taneous coronary interventions to CABG of 19.12 in Korea, 
compared to the average ratio of 5.92 in the Organization 
for Economic Cooperation and Development member 
countries [6,24]. Accordingly, heart valve surgery has be-
come the most common cardiac procedure in Korea, and 
the necessity of developing a risk prediction model specific 
to Korea following heart valve surgery has been pointed 
out.
Using the KHVSR database, we identified 13 readily 
available risk factors for operative mortality that were in-
corporated into the risk prediction models. Of these, ad-
vanced age (≥80 years), an emergent or urgent operation, 
and severe renal dysfunction with an eGFR <30 mL/
min/1.73 m2 were found to be most strongly associated 
with an increased risk of operative mortality, which was 
scored as 2 points in our risk prediction models. These re-
sults imply that timely surgery may reduce the risk of op-
erative mortality before patients become too old or suffer 
from circulatory collapse due to a delayed surgical referral.
Renal dysfunction was also proven to be related to an in-
creased risk of operative mortality after heart valve surgery 
in our cohort. This may be attributed to the higher preva-
lence of comorbidities leading to increased operative com-
plications and higher calcific burdens in the valvular leaf-
lets and annular structures, making surgical procedures 
more technically challenging [25]. It is also noteworthy 
that a consistent trend was found in our study for operative 
mortality and morbidity to be lower in obese patients after 
cardiac surgery, which appeared to be paradoxical and was 
reflected in the risk prediction model (-1 for patients with 
a BMI ≥25 kg/m2) [15].
In designing the risk prediction model, we initially in-
tended to evaluate the procedural burden on the risk of 
mortality by analyzing the extent of heart valve surgery 
(isolated versus combined or aortic root procedure) and the 
performance of concomitant procedures (Table 3). Al-
though the mortality risk was numerically higher in pa-
tients with combined valve surgery (Supplementary Table 
1), the extent of the procedure was not associated with an 
increased risk of mortality in the final multivariable risk 
analysis, and model 2 (incorporating the extent of the pro-
cedure) did not show better discrimination and calibration 
abilities than model 1. As for concomitant procedures, the 
addition of the 2 most common procedures (AF surgery 
and aorta replacement), did not increase the risk of opera-
tive mortality, which is consistent with a recent study [26] 
and guidelines [27,28]. However, concomitant CABG was 
shown to be significantly associated with an increased risk 
of mortality during heart valve surgery, which agrees with 
the STS risk prediction models that evaluate combined val-
vular and coronary bypass surgery as separate procedural 
entities [8].
Our risk prediction models are limited by the small 
number of participating institutions (n=9), which included 
mainly high- and medium-volume centers. As small-vol-
ume centers constitute most of the Korean institutions that 
perform open heart surgery, whether our risk prediction 
model can be applied to patients receiving cardiac surgery 
at such centers warrants further validation. It should also 
be noted that the number of patients in our study cohort 
was relatively small (n=4,742) compared to the number of 
patients enrolled to generate other nation-specific risk pre-
diction models [9,10], as well as the US and European 
models [7,8]. According to annual reports from the Korea 
Heart Foundation (www.heart.or.kr), the nationwide vol-
Table 6. Predicted risk of operative mortality by the risk score in 
models 1 and 2
Risk score
Predicted risk of operative mortality (%)
























ume of heart valve surgery was 3,930 cases from 71 institu-
tions in 2017 and 4,141 cases from 73 institutions in 2018, 
with a mortality rate of 3.9% and 3.2% in 2017 and 2018, 
respectively [29]. Given these nationwide volumes, we esti-
mate that approximately 59% of the patients undergoing 
heart valve surgery in Korea between 2017 and 2018 were 
incorporated into the risk prediction model, and mortality 
occurred in 144 patients (4.3%) at the institutions that did 
not participate in the KHVSR, which is significantly higher 
than the rate at institutions that did participate in the KH-
VSR (3.0%) (p<0.001). Therefore, the risk prediction model 
in this study should be interpreted with caution because of 
selection bias, and future efforts to register a larger num-
ber of patients in the KHVSR across low- to high-volume 
centers are warranted to obtain a more adequately repre-
sentative cohort of patients undergoing heart valve surgery 
in Korea. Thereby, we believe that the current risk predic-
tion model will be more refined in the next version, with a 
larger national cohort of patients undergoing heart valve 
surgery using a more sophisticated KHVSR dataset to dis-
criminate the risk of procedural extent between isolated 
and combined valve surgery and analyze the impact of 
currently unavailable risk variables such as critical status 
(e.g., preoperative extracorporeal membrane oxygenation) 
or frailty.
In conclusion, we developed a risk prediction model ded-
icated to heart valve surgery with a scoring system using 
preoperative patient data from the KHVSR. The operative 
mortality after heart valve surgery can be predicted well 
with this risk prediction model in a Korean cohort. More-
over, the results of the present analyses highlight the sig-
nificance of collaborative nationwide efforts to collect pa-
tient data after cardiac surgery. This risk prediction model 
may also provide an important foundation for the identifi-
cation of high-risk patients, thereby supporting cardiac 
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Fig. 2. (A, B) Calibration for operative mortality in the development sample.
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